Artiva Biotherapeutics, Inc. (ARTV) vs Turn Therapeutics Inc. (TTRX)

A side-by-side comparison of Artiva Biotherapeutics, Inc. and Turn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Artiva Biotherapeutics, Inc. logo
ARTV
Artiva Biotherapeutics, Inc.
$357M
$7.31HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Turn Therapeutics Inc. logo
TTRX
Turn Therapeutics Inc.
$354M
$11.90HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT

Total return — ARTV vs TTRX

growth of $100 · dividends reinvested · last 1y
ARTV +137.7% (+137.7%/yr)TTRX +76.6% (+76.6%/yr)ARTV compounded faster over this window
100200300400Start $1002026$238$177
ARTV TTRX

ARTV vs TTRX: by the numbers

  • •ARTV is the larger company ($357M vs $354M market cap).

Metrics side by side

Valuation

MetricARTVTTRX
P/B ratio1.03516.06

Profitability

MetricARTVTTRX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-26.14%-1229.58%
ROIC-27.16%-84.66%

Go deeper

Full ARTV analysisFull TTRX analysisInteractive comparison tool

Dig into the metrics

Artiva Biotherapeutics ROETurn Therapeutics ROEArtiva Biotherapeutics operating marginTurn Therapeutics operating marginArtiva Biotherapeutics revenue growthTurn Therapeutics revenue growthArtiva Biotherapeutics free cash flowTurn Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.